希腊作为控制 COVID-19 感染传播模型的经验。
The Experience of Greece as a Model to Contain COVID-19 Infection Spread.
机构信息
International Institute of Anticancer Research, Kapandriti, Greece;
Fourth Department of Internal Medicine, Attikon University Hospital, National and Kapodistrian University of Athens, Athens, Greece.
出版信息
In Vivo. 2021 Mar-Apr;35(2):1285-1294. doi: 10.21873/invivo.12380.
Abstract
The severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) emerged in late 2019 and has caused a pandemic known as corona virus disease 2019 (COVID-19), responsible for the death of more than 2 million people worldwide. The outbreak of COVID-19 has posed an unprecedented threat on human lives and public safety. The aim of this review is to describe key aspects of the bio-pathology of the novel disease, and discuss aspects of its spread, as well as targeted protective strategies that can help shape the outcome of the present and future health crises. Greece is used as a model to inhibit SARS-COV-2 spread, since it is one of the countries with the lowest fatality rates among nations of the European Union (E.U.), following two consecutive waves of COVID-19 pandemic. Furthermore, niche research technological approaches and scientific recommendations that emerged during the COVID-19 era are discussed.
摘要
严重急性呼吸系统综合症冠状病毒 2 型（SARS-CoV-2）于 2019 年末出现，并引发了一种被称为 2019 年冠状病毒病（COVID-19）的大流行，导致全球超过 200 万人死亡。COVID-19 的爆发对人类生命和公共安全构成了前所未有的威胁。本综述旨在描述这种新型疾病的生物病理学的关键方面，并讨论其传播的各个方面，以及有针对性的保护策略，这些策略有助于塑造当前和未来健康危机的结果。希腊被用作抑制 SARS-CoV-2 传播的模型，因为它是欧盟（EU）国家中在经历了 COVID-19 大流行的两波疫情后死亡率最低的国家之一。此外，还讨论了 COVID-19 时代出现的利基研究技术方法和科学建议。
相似文献
1
The Experience of Greece as a Model to Contain COVID-19 Infection Spread.希腊作为控制 COVID-19 感染传播模型的经验。
In Vivo. 2021 Mar-Apr;35(2):1285-1294. doi: 10.21873/invivo.12380.
2
A main event and multiple introductions of SARS-CoV-2 initiated the COVID-19 epidemic in Greece.一种主要事件和多种 SARS-CoV-2 的引入引发了希腊的 COVID-19 疫情。
J Med Virol. 2021 May;93(5):2899-2907. doi: 10.1002/jmv.26778. Epub 2021 Feb 23.
3
The Greek Response to COVID-19: A True Success Story from an IBD Perspective.从炎症性肠病角度看希腊对 COVID-19 的应对：一个真正的成功案例。
Inflamm Bowel Dis. 2020 Jul 17;26(8):1144-1148. doi: 10.1093/ibd/izaa143.
4
Epidemiology and precision of SARS-CoV-2 detection following lockdown and relaxation measures.封锁和放宽措施后 SARS-CoV-2 检测的流行病学和精准度。
J Med Virol. 2021 Apr;93(4):2374-2384. doi: 10.1002/jmv.26731. Epub 2020 Dec 29.
5
The impact of lockdown during the COVID-19 pandemic on newly acute myeloid leukemia patients: Single-centre comparative study between 2019 and 2020 cohorts in Madrid.新冠疫情期间封锁措施对新诊断急性髓系白血病患者的影响：马德里2019年与2020年队列的单中心比较研究
Leuk Res. 2021 Feb;101:106518. doi: 10.1016/j.leukres.2021.106518. Epub 2021 Jan 27.
6
Knowledge, attitudes and practices related to the COVID-19 outbreak among Romanian adults with cancer: a cross-sectional national survey.罗马尼亚癌症成年患者对 COVID-19 爆发的相关知识、态度和实践：一项全国横断面调查。
ESMO Open. 2021 Feb;6(1):100027. doi: 10.1016/j.esmoop.2020.100027. Epub 2020 Dec 2.
7
Estimating the impact of public health strategies on the spread of SARS-CoV-2: Epidemiological modelling for Toulouse, France.估算公共卫生策略对 SARS-CoV-2 传播的影响：法国图卢兹的流行病学建模。
Rev Med Virol. 2021 Sep;31(5):1-8. doi: 10.1002/rmv.2224. Epub 2021 Mar 13.
8
A mini-review on the effects of COVID-19 on younger individuals.关于 COVID-19 对年轻人影响的小型综述。
Exp Biol Med (Maywood). 2021 Feb;246(3):293-297. doi: 10.1177/1535370220975118. Epub 2020 Nov 19.
9
Effects of Social Distancing Measures during the First Epidemic Wave of Severe Acute Respiratory Syndrome Infection, Greece.严重急性呼吸系统综合征疫情第一波期间实施社会疏离措施的效果，希腊。
Emerg Infect Dis. 2021 Feb;27(2):452-462. doi: 10.3201/eid2702.203412.
10
Practical laboratory considerations amidst the COVID-19 outbreak: early experience from Singapore.COVID-19 疫情期间的实验室实践注意事项：来自新加坡的早期经验。
J Clin Pathol. 2021 Apr;74(4):257-260. doi: 10.1136/jclinpath-2020-206563. Epub 2020 Mar 20.
引用本文的文献
1
Association of COVID-19 Infection with Sociodemographic, Anthropometric and Lifestyle Factors: A Cross-Sectional Study in an Older Adults' Population Aged over 65 Years Old.新型冠状病毒肺炎感染与社会人口学、人体测量学和生活方式因素的关联：一项针对65岁以上老年人群的横断面研究
Diseases. 2023 Nov 9;11(4):165. doi: 10.3390/diseases11040165.
2
Impact of COVID-19 Pandemic on Fragility Fractures of the Hip: An Interrupted Time-Series Analysis of the Lockdown Periods in Western Greece and Review of the Literature.新冠疫情对髋部脆性骨折的影响：希腊西部封锁期的中断时间序列分析及文献综述
Geriatrics (Basel). 2023 Jul 1;8(4):72. doi: 10.3390/geriatrics8040072.
3
Covid-19 case management in a Greek migrant camp: The Hellenic Red Cross Mobile Health Unit intervention in Nea Malakasa temporary accommodation center.希腊难民营中的新冠疫情病例管理：希腊红十字会流动医疗队在新马拉卡萨临时安置中心的干预措施。
J Migr Health. 2023;7:100184. doi: 10.1016/j.jmh.2023.100184. Epub 2023 Mar 23.
4
Behavioral and Cultural Insights, a Nationwide Study Based on Repetitive Surveys of WHO Behavioral Insights Tool in Greece Regarding COVID-19 Pandemic and Vaccine Acceptance.行为和文化洞察，一项基于对希腊世界卫生组织行为洞察工具针对 COVID-19 大流行和疫苗接种接受情况进行重复调查的全国性研究。
Int J Environ Res Public Health. 2022 Dec 23;20(1):216. doi: 10.3390/ijerph20010216.
5
Time Lag between COVID-19 Diagnosis and Symptoms Onset for Different Population Groups: Evidence That Self-Testing in Schools Was Associated with Timely Diagnosis among Children.不同人群组中2019冠状病毒病诊断与症状出现之间的时间间隔：学校自我检测与儿童及时诊断相关的证据。
Life (Basel). 2022 Aug 25;12(9):1305. doi: 10.3390/life12091305.
6
Do the Kinetics of Antibody Responses Predict Clinical Outcome in Hospitalized Patients With Moderate-to-Severe COVID-19?抗体反应动力学能否预测中重度 COVID-19 住院患者的临床结局？
In Vivo. 2022 Jul-Aug;36(4):1944-1948. doi: 10.21873/invivo.12916.
7
Analysis of Diagnostic Modalities in Hospital-admitted Patients Evaluated for COVID-19.对因COVID-19接受评估的住院患者的诊断方式分析
In Vivo. 2022 May-Jun;36(3):1316-1324. doi: 10.21873/invivo.12832.
8
Axillary Lymph Node Swelling Mimicking Breast Cancer Metastasis After COVID-19 Vaccination: A Japanese Case Report and Literature Review.接种 COVID-19 疫苗后腋窝淋巴结肿胀类似乳腺癌转移：日本病例报告及文献复习。
In Vivo. 2022 Mar-Apr;36(2):1041-1046. doi: 10.21873/invivo.12800.
9
Impact of the COVID-19 Pandemic on Treatment and Oncologic Outcomes for Cancer Patients in Romania.新冠疫情对罗马尼亚癌症患者治疗和肿瘤学结局的影响。
In Vivo. 2022 Mar-Apr;36(2):934-941. doi: 10.21873/invivo.12783.
10
Self-reported Smell and Taste Disorders in Patients With COVID-19: A Japanese Single-center Study.《COVID-19 患者的自我报告嗅觉和味觉障碍：一项日本单中心研究》。
In Vivo. 2022 Mar-Apr;36(2):918-924. doi: 10.21873/invivo.12781.
本文引用的文献
1
Preliminary report of an outbreak of SARS-CoV-2 in mink and mink farmers associated with community spread, Denmark, June to November 2020.丹麦 2020 年 6 月至 11 月与社区传播相关的 SARS-CoV-2 在水貂和水貂养殖者中的暴发的初步报告。
Euro Surveill. 2021 Feb;26(5). doi: 10.2807/1560-7917.ES.2021.26.5.210009.
2
Mechanistic transmission modeling of COVID-19 on the cruise ship demonstrates the importance of aerosol transmission.新冠病毒在游轮上的机械传播建模表明了气溶胶传播的重要性。
Proc Natl Acad Sci U S A. 2021 Feb 23;118(8). doi: 10.1073/pnas.2015482118.
3
Vaccinating against covid-19 in people who report allergies.为有过敏史的人接种新冠疫苗。
BMJ. 2021 Jan 18;372:n120. doi: 10.1136/bmj.n120.
4
Anaphylaxis to the first COVID-19 vaccine: is polyethylene glycol (PEG) the culprit?对第一剂新冠疫苗过敏：聚乙二醇（PEG）是罪魁祸首吗？
Br J Anaesth. 2021 Mar;126(3):e106-e108. doi: 10.1016/j.bja.2020.12.020. Epub 2020 Dec 17.
5
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.mRNA-1273 新型冠状病毒疫苗的有效性和安全性。
N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30.
6
Genetic mechanisms of critical illness in COVID-19.新型冠状病毒肺炎危重症的遗传机制。
Nature. 2021 Mar;591(7848):92-98. doi: 10.1038/s41586-020-03065-y. Epub 2020 Dec 11.
7
Meteorological factors, governmental responses and COVID-19: Evidence from four European countries.气象因素、政府应对措施与 COVID-19：来自四个欧洲国家的证据。
Environ Res. 2021 Mar;194:110596. doi: 10.1016/j.envres.2020.110596. Epub 2020 Dec 9.
8
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.ChAdOx1 nCoV-19 疫苗（阿斯利康）对 SARS-CoV-2 的安全性和有效性：巴西、南非和英国四项随机对照试验的中期分析。
Lancet. 2021 Jan 9;397(10269):99-111. doi: 10.1016/S0140-6736(20)32661-1. Epub 2020 Dec 8.
9
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
10
SARS-CoV-2 receptor ACE2 is co-expressed with genes related to transmembrane serine proteases, viral entry, immunity and cellular stress.SARS-CoV-2 受体 ACE2 与与跨膜丝氨酸蛋白酶、病毒进入、免疫和细胞应激相关的基因共同表达。
Sci Rep. 2020 Dec 8;10(1):21415. doi: 10.1038/s41598-020-78402-2.
Zotero 插件